DMAA - Drugs Made In America Acquisition Corp. Ordinary Shares Stock Earnings Estimates & Analysis - Investorconsensus.com

Loading live market data…

Is Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) a Buy, Sell, or Hold?

Enter your email address below for free access to our Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) research center and poll results.

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

$10.68 USD

$0.01 (0.09%)

Volume: 464
Average Volume: 111.47K
Market Capitalization: $360.1M
P/E Ratio: 52.20
Dividend Yield: 0.00%

Price Target: $
Year High: $10.69
Year Low: $10.21
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $0.03

DMAA Estimated and Actual Revenue by Quarter

DMAA Estimated and Actual EPS by Quarter

DMAA Analyst Forecasts